Back

Soluble ST2 in patients with heart failure with preserved ejection fraction and its prognostic value: results from the Aldo-DHF trial

29 May 2018 (08:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Leonhard Schleussner

Heart Center - University Hospital Dresden, Dresden (Germany)

25 More presentations in this session

Presentation thumbnail
Professor M. Senni (Bergamo, IT)
Abstract
Presentation thumbnail
Presentation thumbnail
Doctor I. Alexanian (Athens, GR)
Presentation thumbnail
Doctor M. Feola (Mondovi, IT)
Abstract
Presentation thumbnail
Professor N. Lyamina (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

29 May 2018 08:00 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources